Excretion of thromboxane A2 and prostacyclin metabolites before and after exercise testing in patients with and without signs of ischemic heart disease.
- 1 November 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 82 (5) , 1737-1743
- https://doi.org/10.1161/01.cir.82.5.1737
Abstract
We addressed the hypothesis that platelets are not activated in association with effort-induced myocardial ischemia in stable coronary disease. Seventy-two patients undergoing a diagnostic bicycle exercise test were stratified according to the development of chest pain (yes/no, 33/39) and of exercise-induced ST-segment depression of at least 200 microV in the electrocardiogram (yes/no, 12/60). Noninvasive indexes of platelet activation and of platelet/vessel wall interaction (urinary excretion of the 2,3-dinor-metabolites of thromboxane A2 [Tx-M] and prostacyclin [PGI-M], respectively) were analyzed in samples collected in the basal state and after the test. Basal Tx-M and PGI-M did not differ in patients with (236 +/- 35 and 131 +/- 22 pg/mg creatinine, respectively) and without (185 +/- 16 and 101 +/- 13 pg/mg creatinine, respectively) chest pain, or in those with (178 +/- 45 and 162 +/- 41 pg/mg, respectively) and without (216 +/- 22 and 104 +/- 11 pg/mg, respectively) ST-segment depression during the test. Patients without chest pain or without ST-segment depression moderately increased (p less than 0.05) their urinary Tx-M (by 21% and 13%, respectively) and PGI-M (by 28% and 23%, respectively) after exercise. No significant increases were observed in those developing chest pain or ST depression during exercise. These data indicate that effort-induced myocardial ischemia is not associated with an increase in platelet activation or platelet/vessel wall interaction in patients with stable coronary disease.This publication has 24 references indexed in Scilit:
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.Heart, 1986
- Flow Effects on Prostacyclin Production by Cultured Human Endothelial CellsScience, 1985
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Lack of Release of Platelet Factor 4 during Exercise-Induced Myocardial IschemiaNew England Journal of Medicine, 1981
- Platelet Activation during Exercise-Induced Myocardial IschemiaNew England Journal of Medicine, 1980
- Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery diseaseThe American Journal of Cardiology, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976